Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia

Paula T. Trzepacz, Peng Yu, Jia Sun, Kory Schuh, Michael Case, Michael M. Witte, Helen Hochstetler, Ann Hake

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

In this study we compared Pittsburgh compound-B (PIB) positron emission tomography (PET) amyloid imaging, fluorodeoxyglucose PET for metabolism, and magnetic resonance imaging (MRI) for structure to predict conversion from amnestic mild cognitive impairment (MCI) to Alzheimer's dementia using data from the Alzheimer's Disease Neuroimaging Initiative cohort. Numeric neuroimaging variables generated by the Alzheimer's Disease Neuroimaging Initiative-funded laboratories for each neuroimaging modality along with apolipoprotein-E genotype (n= 29) were analyzed. Performance of these biomarkers for predicting conversion from MCI to Alzheimer's dementia at 2 years was evaluated in 50 late amnestic MCI subjects, 20 of whom converted. Multivariate modeling found that among individual modalities, MRI had the highest predictive accuracy (67%) which increased by 9% to 76% when combined with PIB-PET, producing the highest accuracy among any biomarker combination. Individually, PIB-PET generated the best sensitivity, and fluorodeoxyglucose PET had the lowest. Among individual brain regions, the temporal cortex was found to be most predictive for MRI and PIB-PET.

Original languageEnglish
Pages (from-to)143-151
Number of pages9
JournalNeurobiology of Aging
Volume35
Issue number1
DOIs
StatePublished - Jan 2014

Fingerprint

Neuroimaging
Positron-Emission Tomography
Alzheimer Disease
Magnetic Resonance Imaging
Biomarkers
Apolipoproteins E
Temporal Lobe
Amyloid
Cognitive Dysfunction
Genotype
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole
Brain

Keywords

  • ADNI
  • Alzheimer's disease
  • Amyloid imaging
  • ApoE
  • Biomarkers
  • Conversion
  • Dementia
  • FDG-PET
  • Mild cognitive impairment
  • MRI
  • Neuroimaging
  • PIB-PET

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)
  • Aging
  • Developmental Biology
  • Geriatrics and Gerontology

Cite this

Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia. / Trzepacz, Paula T.; Yu, Peng; Sun, Jia; Schuh, Kory; Case, Michael; Witte, Michael M.; Hochstetler, Helen; Hake, Ann.

In: Neurobiology of Aging, Vol. 35, No. 1, 01.2014, p. 143-151.

Research output: Contribution to journalArticle

Trzepacz, Paula T. ; Yu, Peng ; Sun, Jia ; Schuh, Kory ; Case, Michael ; Witte, Michael M. ; Hochstetler, Helen ; Hake, Ann. / Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia. In: Neurobiology of Aging. 2014 ; Vol. 35, No. 1. pp. 143-151.
@article{2102a0bc48b3401b9ce68d6851f5e053,
title = "Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia",
abstract = "In this study we compared Pittsburgh compound-B (PIB) positron emission tomography (PET) amyloid imaging, fluorodeoxyglucose PET for metabolism, and magnetic resonance imaging (MRI) for structure to predict conversion from amnestic mild cognitive impairment (MCI) to Alzheimer's dementia using data from the Alzheimer's Disease Neuroimaging Initiative cohort. Numeric neuroimaging variables generated by the Alzheimer's Disease Neuroimaging Initiative-funded laboratories for each neuroimaging modality along with apolipoprotein-E genotype (n= 29) were analyzed. Performance of these biomarkers for predicting conversion from MCI to Alzheimer's dementia at 2 years was evaluated in 50 late amnestic MCI subjects, 20 of whom converted. Multivariate modeling found that among individual modalities, MRI had the highest predictive accuracy (67{\%}) which increased by 9{\%} to 76{\%} when combined with PIB-PET, producing the highest accuracy among any biomarker combination. Individually, PIB-PET generated the best sensitivity, and fluorodeoxyglucose PET had the lowest. Among individual brain regions, the temporal cortex was found to be most predictive for MRI and PIB-PET.",
keywords = "ADNI, Alzheimer's disease, Amyloid imaging, ApoE, Biomarkers, Conversion, Dementia, FDG-PET, Mild cognitive impairment, MRI, Neuroimaging, PIB-PET",
author = "Trzepacz, {Paula T.} and Peng Yu and Jia Sun and Kory Schuh and Michael Case and Witte, {Michael M.} and Helen Hochstetler and Ann Hake",
year = "2014",
month = "1",
doi = "10.1016/j.neurobiolaging.2013.06.018",
language = "English",
volume = "35",
pages = "143--151",
journal = "Neurobiology of Aging",
issn = "0197-4580",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to alzheimer's dementia

AU - Trzepacz, Paula T.

AU - Yu, Peng

AU - Sun, Jia

AU - Schuh, Kory

AU - Case, Michael

AU - Witte, Michael M.

AU - Hochstetler, Helen

AU - Hake, Ann

PY - 2014/1

Y1 - 2014/1

N2 - In this study we compared Pittsburgh compound-B (PIB) positron emission tomography (PET) amyloid imaging, fluorodeoxyglucose PET for metabolism, and magnetic resonance imaging (MRI) for structure to predict conversion from amnestic mild cognitive impairment (MCI) to Alzheimer's dementia using data from the Alzheimer's Disease Neuroimaging Initiative cohort. Numeric neuroimaging variables generated by the Alzheimer's Disease Neuroimaging Initiative-funded laboratories for each neuroimaging modality along with apolipoprotein-E genotype (n= 29) were analyzed. Performance of these biomarkers for predicting conversion from MCI to Alzheimer's dementia at 2 years was evaluated in 50 late amnestic MCI subjects, 20 of whom converted. Multivariate modeling found that among individual modalities, MRI had the highest predictive accuracy (67%) which increased by 9% to 76% when combined with PIB-PET, producing the highest accuracy among any biomarker combination. Individually, PIB-PET generated the best sensitivity, and fluorodeoxyglucose PET had the lowest. Among individual brain regions, the temporal cortex was found to be most predictive for MRI and PIB-PET.

AB - In this study we compared Pittsburgh compound-B (PIB) positron emission tomography (PET) amyloid imaging, fluorodeoxyglucose PET for metabolism, and magnetic resonance imaging (MRI) for structure to predict conversion from amnestic mild cognitive impairment (MCI) to Alzheimer's dementia using data from the Alzheimer's Disease Neuroimaging Initiative cohort. Numeric neuroimaging variables generated by the Alzheimer's Disease Neuroimaging Initiative-funded laboratories for each neuroimaging modality along with apolipoprotein-E genotype (n= 29) were analyzed. Performance of these biomarkers for predicting conversion from MCI to Alzheimer's dementia at 2 years was evaluated in 50 late amnestic MCI subjects, 20 of whom converted. Multivariate modeling found that among individual modalities, MRI had the highest predictive accuracy (67%) which increased by 9% to 76% when combined with PIB-PET, producing the highest accuracy among any biomarker combination. Individually, PIB-PET generated the best sensitivity, and fluorodeoxyglucose PET had the lowest. Among individual brain regions, the temporal cortex was found to be most predictive for MRI and PIB-PET.

KW - ADNI

KW - Alzheimer's disease

KW - Amyloid imaging

KW - ApoE

KW - Biomarkers

KW - Conversion

KW - Dementia

KW - FDG-PET

KW - Mild cognitive impairment

KW - MRI

KW - Neuroimaging

KW - PIB-PET

UR - http://www.scopus.com/inward/record.url?scp=84885180697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885180697&partnerID=8YFLogxK

U2 - 10.1016/j.neurobiolaging.2013.06.018

DO - 10.1016/j.neurobiolaging.2013.06.018

M3 - Article

VL - 35

SP - 143

EP - 151

JO - Neurobiology of Aging

JF - Neurobiology of Aging

SN - 0197-4580

IS - 1

ER -